Clinical Terminology Needs in Health IT Markets—Opportunity Analysis

Standardization Supports Foray into New Markets and Applications, SNOMED CT to Unlock Strong Growth Potential in Healthcare Big Data, Genomics, and Pharmacy IT

USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

Healthcare interoperability is a global challenge for industry stakeholders. While a number of organizations are working towards developing and implementing industry standards, challenges emerge every day as technologies and their uses evolve. Advances in Big Data, genomics, and pharmacy information technology (IT) are helping to identify new applications and markets for healthcare IT, which will require a fresh approach towards standardization. This research, conducted in collaboration with the International Health Terminology Standards Organization (IHTSDO), explores opportunities for SNOMED CT expansion in emerging healthcare IT markets.

Table of Contents

Clinical Terminology Needs in Health IT Markets—Opportunity AnalysisExecutive SummaryExecutive SummaryExecutive Summary (continued)Executive Summary (continued)Interoperability in Modern HealthcareWhat is Healthcare Interoperability?Healthcare Interoperability ChallengesRole of SNOMED CT in Healthcare InteroperabilitySNOMED CT’s PotentialEmerging Needs for SNOMED CTSNOMED CT ExpansionClinical Terminology Needs in Healthcare Big DataBig Data OverviewHealthcare Big DataHealthcare Big Data ThemesBig Data RoadmapHealthcare Provider Big Data ApplicationsHealthcare Provider Big Data Applications (continued)Healthcare Consumer Big Data ApplicationsHealthcare Big Data InitiativesHealthcare Big Data MarketHealthcare Big Data EcosystemMonetization StrategiesInteroperability ChallengesInteroperability InitiativesInteroperability Initiatives (continued)Drivers and Restraints—SNOMED CT AdoptionHealthcare Big Data OpportunitiesSNOMED CT and Big DataSNOMED CT and Big Data (continued)Key Industry ParticipantsClinical Terminology Needs in GenomicsGenomics EcosystemGenomics Market StagePersonalized GenomicsPersonalized Genomics (continued)Interoperability ChallengesInteroperability InitiativesDrivers and Restraints—SNOMED CT AdoptionGenomics OpportunitiesSNOMED CT and GenomicsClinical Terminology Needs in Pharmacy ITPharmacy IT OverviewPharmacy Business Model TransformationRegulations and TrendsInteroperability ChallengesInteroperability InitiativesInteroperability Initiatives (continued)Drivers and Restraints—SNOMED CT AdoptionPharmacy IT OpportunitiesSNOMED CT and Pharmacy ITLegal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue PropositionGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.